Hap Trading, LLC Ventyx Biosciences, Inc. Transaction History
Hap Trading, LLC
- $1.15 Trillion
- Q4 2024
A detailed history of Hap Trading, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 12,600 shares of VTYX stock, worth $13,860. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,600Holding current value
$13,860% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VTYX
# of Institutions
133Shares Held
55.2MCall Options Held
81.4KPut Options Held
148K-
Black Rock Inc. New York, NY4.77MShares$5.25 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.48MShares$4.93 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.27MShares$4.7 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY4.05MShares$4.45 Million3.31% of portfolio
-
Ubs Group Ag3.78MShares$4.16 Million0.0% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $62.2M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...